Cargando…
Nanovaccines: Merits, and diverse roles in boosting antitumor immune responses
An attractive type of cancer immunotherapy is cancer therapeutic vaccines that induce antitumor immunity effectively. Although supportive results in the recent vaccine studies, there are still numerous drawbacks, such as poor stability, weak immunogenicity and strong toxicity, to be tackled for prom...
Autores principales: | Yin, Qiliang, Wang, Ying, Xiang, Yipeng, Xu, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746515/ https://www.ncbi.nlm.nih.gov/pubmed/36170662 http://dx.doi.org/10.1080/21645515.2022.2119020 |
Ejemplares similares
-
Regulatory T cell therapy for multiple sclerosis: Breaching (blood-brain) barriers
por: Verreycken, Janne, et al.
Publicado: (2022) -
Immune checkpoint inhibitors in esophageal cancer: Clinical development and perspectives
por: Nagata, Yusuke, et al.
Publicado: (2022) -
Therapeutic potential of mesenchymal stem cells for refractory inflammatory and immune skin diseases
por: Hua, Chunting, et al.
Publicado: (2022) -
Immunotherapy of glioblastoma: Recent advances and future prospects
por: Yuan, Boyang, et al.
Publicado: (2022) -
The progress of peptide vaccine clinical trials in gynecologic oncology
por: Tang, Mi, et al.
Publicado: (2022)